Related News
Home » Metro » Health and Science
No mutation in flu virus so far
SHANGHAI researchers who decoded the genetic structure of the swine flu virus in two local patients have concluded that no major mutations have taken place during its journey from other parts of the world.
The genome sequencing, involving H1N1 virus samples taken from two patients at the Shanghai Public Health Clinical Center, followed similar work by researchers in Beijing and Guangzhou.
Experts at the center said yesterday that the virus was the same as the one found in the United States and Australia, indicating that no genetic changes had occurred during the transmission process. Similar tests will be done on future flu patients to track possible mutations.
The local strains were obtained last Wednesday from a swine flu patient who arrived in Shanghai on May 23 from Australia and on Sunday from a patient who came in from the US on May 30.
"Getting the virus strain is very important for studying the development of the virus and enhancing research on reagents, vaccines and other medicines," said Lu Hongzhou, vice director of the Shanghai center.
On the prevention front, the Shanghai Institute of Biological Products expects to receive a swine flu virus strain sent by the World Health Organization this week to begin vaccine production.
The genome sequencing, involving H1N1 virus samples taken from two patients at the Shanghai Public Health Clinical Center, followed similar work by researchers in Beijing and Guangzhou.
Experts at the center said yesterday that the virus was the same as the one found in the United States and Australia, indicating that no genetic changes had occurred during the transmission process. Similar tests will be done on future flu patients to track possible mutations.
The local strains were obtained last Wednesday from a swine flu patient who arrived in Shanghai on May 23 from Australia and on Sunday from a patient who came in from the US on May 30.
"Getting the virus strain is very important for studying the development of the virus and enhancing research on reagents, vaccines and other medicines," said Lu Hongzhou, vice director of the Shanghai center.
On the prevention front, the Shanghai Institute of Biological Products expects to receive a swine flu virus strain sent by the World Health Organization this week to begin vaccine production.
- About Us
- |
- Terms of Use
- |
-
RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.